Michele Ortenzi
Papers
3
Total Citations
17
H-Index
2
About
Michele Ortenzi is a urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH) and prostate cancer. His research focuses on optimizing surgical outcomes through robotic-assisted techniques, augmented reality guidance, and novel ablation therapies. Ortenzi led the prospective randomized RIDERS Trial, a landmark study comparing artificial intelligence–enhanced 3D augmented reality–guided robotic prostatectomy against cognitive MRI intervention, demonstrating his commitment to integrating cutting-edge technology into the operating room. He has also made significant contributions to the evaluation of functional outcomes after BPH surgery, particularly through the standardized BPH-6 achievement metric—a composite endpoint that balances effective de-obstruction with preservation of ejaculatory function. His multicentric studies comparing waterjet ablation therapy and urethral-sparing robot-assisted simple prostatectomy for large prostates (>80 mL) have helped clarify optimal treatment pathways for complex patients. With citations accumulating across his publications, Ortenzi’s work is shaping evidence-based surgical decision-making and pushing the boundaries of what is possible in urologic reconstruction and functional preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3